title: Hemolysis during low-dose sulfasalazine treatment in rheumatoid arthritis patients.
authors.affiliation: Dept. of Rheumatology, University Hospital Nijmegen, The Netherlands.
authors.forename: M J
authors.initials: MJ
authors.lastname: Wijnands
authors.forename: I H
authors.initials: IH
authors.lastname: Nuver-Zwart
authors.forename: P L
authors.initials: PL
authors.lastname: van Riel
authors.forename: M A
authors.initials: MA
authors.lastname: van 't Hof
authors.forename: F W
authors.initials: FW
authors.lastname: Gribnau
authors.forename: L B
authors.initials: LB
authors.lastname: van De Putte
mesh_terms: D001172:Arthritis, Rheumatoid / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D004305:Dose-Response Relationship, Drug; D006242:Haptoglobins / Q000032:analysis; D006454:Hemoglobins / Q000032:analysis; D006461:Hemolysis; D006466:Hemopexin / Q000032:analysis; D006801:Humans; D012460:Sulfasalazine / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D006242:Haptoglobins; D006454:Hemoglobins; D012460:Sulfasalazine; D006466:Hemopexin